Q4 2024 Holdings
Filed 2025-02-04 | 36 holdings | $210.8M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| ELI Lilly & Co(LLY) | COM | 532457108 | $28.7M | 37,068 | 13.6% |
| Unitedhealth Group Inc(UNH) | COM | 91324P102 | $17.9M | 35,202 | 8.5% |
| Abbvie Inc(ABBV) | COM | 00287Y109 | $16.0M | 90,723 | 7.6% |
| Boston Scientific Corp(BSX) | COM | 101137107 | $13.8M | 154,222 | 6.6% |
| Thermo Fisher Scientific Inc(TMO) | COM | 883556102 | $12.9M | 24,896 | 6.1% |
| Merck & Co Inc(MRK) | COM | 58933Y105 | $10.4M | 105,727 | 4.9% |
| Stryker Corporation(SYK) | COM | 863667101 | $9.3M | 25,660 | 4.4% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $9.3M | 67,763 | 4.4% |
| Alkermes PLC(ALKS) | SHS | G01767105 | $7.7M | 266,499 | 3.6% |
| Vertex Pharmaceuticals Inc(VRTX) | COM | 92532F100 | $7.6M | 22,257 | 3.6% |
| Cencora Inc(COR) | COM | 03073E105 | $7.3M | 32,553 | 3.5% |
| Amgen Inc(AMGN) | COM | 031162100 | $7.1M | 27,414 | 3.4% |
| Intra-Cellular Therapies Inc(ITCIEUR) | COM | 46116X101 | $5.9M | 71,138 | 2.8% |
| Edwards Lifesciences Corp(EW) | COM | 28176E108 | $5.1M | 68,296 | 2.4% |
| Mirum Pharmaceuticals Inc(MIRM) | COM | 604749101 | $4.8M | 116,692 | 2.3% |
| Dexcom Inc(DXCM) | COM | 252131107 | $4.7M | 60,057 | 2.2% |
| Harmony Biosciences Hldgs in(HRMY) | COM | 413197104 | $4.1M | 120,501 | 1.9% |
| Cardinal Health Inc(CAH) | COM | 14149Y108 | $3.6M | 30,680 | 1.7% |
| Newamsterdam Pharma Company(NAMS) | ORDINARY SHARES | N62509109 | $3.6M | 138,983 | 1.7% |
| Arcellx Inc(ACLX) | COMMON STOCK | 03940C100 | $3.3M | 42,071 | 1.6% |
| UFP Technologies Inc(UFPT) | COM | 902673102 | $3.2M | 23,159 | 1.5% |
| Amicus Therapeutics Inc(FOLD) | COM | 03152W109 | $3.1M | 326,840 | 1.5% |
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $2.8M | 103,032 | 1.3% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $2.7M | 62,161 | 1.3% |
| Merus N V | COM | N5749R100 | $2.6M | 62,521 | 1.2% |
| Janux Therapeutics Inc(JANX) | COM | 47103J105 | $2.1M | 39,573 | 1.0% |
| Beigene LTD(ONC) | SPONSORED ADR | 07725L102 | $2.0M | 10,900 | 1.0% |
| Krystal Biotech Inc(KRYS) | COM | 501147102 | $1.5M | 9,202 | 0.7% |
| Mereo Biopharma Group PLC(MREO) | SPON ADS | 589492107 | $1.4M | 390,000 | 0.7% |
| Summit Therapeutics Inc(SMMT) | COM | 86627T108 | $1.3M | 101,177 | 0.6% |
| Corbus Pharmaceuticals Hldgs(CRBP) | COM NEW | 21833P301 | $1.2M | 98,304 | 0.6% |
| Autolus Therapeutics PLC(AUTL) | SPON ADS | 05280R100 | $1.1M | 479,644 | 0.5% |
| Soleno Therapeutics Inc(SLNO) | COM | 834203309 | $984.8K | 30,940 | 0.5% |
| Mersana Therapeutics Inc | COM | 59045L106 | $764.8K | 538,621 | 0.4% |
| Pharvaris N V(PHVS) | COM | N69605108 | $652.9K | 34,328 | 0.3% |
| Cabaletta BIO Inc(CABA) | COM | 12674W109 | $554.3K | 247,454 | 0.3% |